Evidence map›Paper›PMID 30106875›Full record

ArticleShock (Augusta, Ga.)2018

Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis.

Marcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, Michael Bauer, Mihaly Boros, Jean-Marc Cavaillon, Irshad H Chaudry, Craig M Coopersmith, Clifford S Deutschman, Susanne Drechsler and 21 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Shock (Augusta, Ga.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 2 pooled it
20.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 2 syntheses or guidelines pooled it, 259 citations in OpenAlex.

  1. Pooled it
  2. Understanding and Enhancing Sepsis Survivorship. Priorities for Research and Practice.American journal of respiratory and critical care medicine · 2019
    Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Myeloid-derived suppressor cells in sepsis: drivers of persistent immunosuppression and targets for precision immunotherapy.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Sympathetic regulation of the host immune response to bacterial sepsis.Clinical science (London, England : 1979) · 2025
    Review
  18. Article
  19. Article
  20. Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 13 countries.

Marcin F OsuchowskiLudwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria.
Alfred AyalaRhode Island Hospital and Alpert School of Medicine at Brown University, Providence, Rhode Island.
Soheyl BahramiLudwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria.
Michael BauerJena University Hospital, Jena, Germany.
Mihaly BorosInstitute of Surgical Research, University of Szeged, Szeged, Hungary.
Jean-Marc CavaillonInstitut Pasteur, Paris, France.
Irshad H ChaudryUniversity of Alabama at Birmingham School of Medicine, Birmingham, Alabama.
Craig M CoopersmithEmory University School of Medicine, Atlanta, Georgia.
Clifford S DeutschmanFeinstein Institute for Medical Research, Northwell Health, Manhasset, New York.
Susanne DrechslerLudwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria.
Philip EfronUniversity of Florida College of Medicine, Gainesville, Florida.
Claes FrostellDivision of Anaesthesia and Intensive Care, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
Gerhard FritschAUVA Trauma Center, Vienna, Austria.
Waldemar GozdzikWroclaw Medical University, Wroclaw, Poland.
Judith HellmanUniversity of California School of Medicine, San Francisco, California.
Markus Huber-LangInstitute of Clinical and Experimental Trauma-Immunology, University Hospital of Ulm, Ulm, Germany.
Shigeaki InoueKobe University Graduate School of Medicine, Kobe, Japan.
Sylvia KnappMedical University Vienna, Department of Medicine 1, Vienna, Austria.
Andrey V KozlovLudwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria.
Claude LibertCenter for Inflammation Research, VIB, Ghent, Belgium.
John C MarshallKeenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Canada.
Lyle L MoldawerUniversity of Florida College of Medicine, Gainesville, Florida.
Peter RadermacherInstitute of Anaesthesiological Pathophysiology and Process Development, University Hospital of Ulm, Ulm, Germany.
Heinz RedlLudwig Boltzmann Institute for Experimental and Clinical Traumatology in the AUVA Research Center, Vienna, Austria.
Daniel G RemickBoston University School of Medicine, Boston, Massachusetts.
Mervyn SingerBloomsbury Institute of Intensive Care Medicine, University College London, UK.
Christoph ThiemermannThe William Harvey Research Institute, Barts and London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Ping WangFeinstein Institute for Medical Research, Manhasset, New York.
W Joost WiersingaDivision of Infectious Diseases, and Center for Experimental and Molecular Medicine, the Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Xianzhong XiaoXiangya School of Medicine, Central South University, Chagnsha, Hunan, China.
Basilia ZingarelliDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, College of Medicine, University of Cincinnati, Cincinnati, Ohio.
Ludwig Boltzmann Institute for Experimental and Clinical Traumatology · ATUniversity of Alabama at Birmingham · USUniversity of Szeged · HUUniversity Hospital Ulm · DEAcademic Medical Center · NLBrown University · USCentral South University · CNFeinstein Institute for Medical Research · USFlorida College · USInstitut Pasteur · FRJena University Hospital · DEKarolinska Institutet · SEMedical University of Vienna · ATNorthwell Health · USRhode Island Hospital · USSt. Michael's Hospital · CAUniversity College London · GBUniversity of Cincinnati · USUniversity of Florida · USWilliam Harvey Research Institute · GB

Funding

Mechanisms of Immune Dysfunction and Morbid Outcome in Response to Shock/SepsisR35GM118097 · NIGMS · RHODE ISLAND HOSPITAL · PI AYALA, ALFRED · 2016 to 2025
$6.3M
NIGMS NIH HHS R35 GM118097
6 · The paper itself

Abstract

Preclinical animal studies precede the majority of clinical trials. While the clinical definitions of sepsis and recommended treatments are regularly updated, a systematic review of preclinical models of sepsis has not been done and clear modeling guidelines are lacking. To address this deficit, a Wiggers-Bernard Conference on preclinical sepsis modeling was held in Vienna in May, 2017. The goal of the conference was to identify limitations of preclinical sepsis models and to propose a set of guidelines, defined as the "Minimum Quality Threshold in Preclinical Sepsis Studies" (MQTiPSS), to enhance translational value of these models. A total of 31 experts from 13 countries participated and were divided into six thematic Working Groups: Study Design, Humane modeling, Infection types, Organ failure/dysfunction, Fluid resuscitation, and Antimicrobial therapy endpoints. As basis for the MQTiPSS discussions, the participants conducted a literature review of the 260 most highly cited scientific articles on sepsis models (2002-2013). Overall, the participants reached consensus on 29 points; 20 at "recommendation" and nine at "consideration" strength. This Executive Summary provides a synopsis of the MQTiPSS consensus. We believe that these recommendations and considerations will serve to bring a level of standardization to preclinical models of sepsis and ultimately improve translation of preclinical findings. These guideline points are proposed as "best practices" for animal models of sepsis that should be implemented. To encourage its wide dissemination, this article is freely accessible on the Intensive Care Medicine Experimental and Infection journal websites. In order to encourage its wide dissemination, this article is freely accessible in Shock, Infection, and Intensive Care Medicine Experimental.

Indexed as

Disease Models, AnimalSepsisAnimalsBiomedical ResearchConsensus

Identifiers

PMID30106875
PMCPMC6133201
OpenAlexW2999149075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.